CNB FINL PA REPS(CCNEP) - 2025 Q2 - Quarterly Report
2025-08-07 20:15
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-39472 CNB FINANCIAL CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 25-1450605 (State or other jurisdiction ...
HireQuest(HQI) - 2025 Q2 - Quarterly Results
2025-08-07 20:14
Exhibit 99.1 HireQuest Reports Financial Results for Second Quarter 2025 GOOSE CREEK, South Carolina – August 7, 2025 – HireQuest, Inc. (Nasdaq: HQI), a national franchisor of on-demand staffing and executive search services, today reported financial results for the second quarter ended June 30, 2025. Rick Hermanns, HireQuest's President and Chief Executive Officer, commented, "We continued to deliver solid results and profitability in the second quarter of 2025 despite the protracted softness in the staffi ...
Ingles Markets(IMKTA) - 2025 Q3 - Quarterly Report
2025-08-07 20:14
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 28, 2025 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-14706. INGLES MARKETS, INCORPORATED (Exact name of registrant as specified in its charter) North Carolina 56-0846267 (State or oth ...
Integral Ad Science (IAS) - 2025 Q2 - Quarterly Results
2025-08-07 20:14
Total revenue increased 16% to $149.2 million Net income increased to $16.4 million at an 11% margin; adjusted EBITDA increased to $51.6 million at a 35% margin Increases full year financial outlook on strong second quarter results NEW YORK – August 7, 2025 – Integral Ad Science (Nasdaq: IAS), a leading global media measurement and optimization platform, today announced financial results for the second quarter ended June 30, 2025. "We grew revenue 16% with gains in all of our businesses driven by strong ado ...
JFrog(FROG) - 2025 Q2 - Quarterly Results
2025-08-07 20:14
Exhibit 99.1 JFrog Announces Second Quarter 2025 Results Recent Business & Product Highlights 1 • Total Revenues of $127.2 million; up 23% Year-over-Year • Cloud Revenues of $57.1 million; up 45% Year-over-Year • Customers with ARR greater than $1 million equaled 61, up 45% Year-over-Year • Released remote AI MCP server & partnered with NVIDIA's Enterprise AI Factory • Revenue for the second quarter of 2025 was $127.2 million, up 23% year-over-year. • GAAP Gross Profit was $97.0 million; GAAP Gross Margin w ...
GCM Grosvenor(GCMG) - 2025 Q2 - Quarterly Report
2025-08-07 20:14
Part I [Item 1. Financial Statements (unaudited)](index=5&type=section&id=Item%201.%20Financial%20Statements%20(unaudited)) GCM Grosvenor Inc. reported significant net income growth in Q2 and H1 2025, driven by fair value changes and improved financial position [Condensed Consolidated Statements of Financial Condition](index=5&type=section&id=Condensed%20Consolidated%20Statements%20of%20Financial%20Condition) Total assets increased to **$636.9 million** while total liabilities decreased, significantly improving the total deficit to **$(20.6) million** Condensed Consolidated Statements of Financial Condition (in thousands) | Account | June 30, 2025 (Unaudited) | December 31, 2024 | | :--- | :--- | :--- | | **Assets** | | | | Cash and cash equivalents | $136,334 | $89,454 | | Investments | $262,755 | $257,807 | | Total assets | $636,859 | $612,731 | | **Liabilities and Equity** | | | | Accrued compensation | $60,782 | $112,519 | | Debt | $430,235 | $432,039 | | Warrant liabilities | $11,280 | $22,510 | | Total liabilities | $657,498 | $703,070 | | Total deficit | $(20,639) | $(90,339) | | Total liabilities and equity (deficit) | $636,859 | $612,731 | [Condensed Consolidated Statements of Income (Loss)](index=7&type=section&id=Condensed%20Consolidated%20Statements%20of%20Income%20(Loss)) Net income significantly increased in Q2 and H1 2025, driven by higher operating revenues and a positive change in warrant liabilities fair value Key Income Statement Data (in thousands, except per share data) | Metric | Q2 2025 | Q2 2024 | H1 2025 | H1 2024 | | :--- | :--- | :--- | :--- | :--- | | Management fees | $101,924 | $99,843 | $211,239 | $195,728 | | Incentive fees | $16,258 | $16,037 | $31,326 | $26,155 | | **Total operating revenues** | **$119,657** | **$116,954** | **$245,503** | **$225,820** | | Operating income (loss) | $19,245 | $20,835 | $34,575 | $4,875 | | Change in fair value of warrant liabilities | $19,388 | $(180) | $10,612 | $(2,324) | | **Net income (loss)** | **$39,891** | **$12,961** | **$38,801** | **$(5,946)** | | Net income attributable to GCMG Inc. | $15,437 | $4,800 | $15,900 | $6,924 | | Diluted EPS | $0.05 | $0.04 | $0.07 | $(0.08) | [Condensed Consolidated Statements of Cash Flows](index=11&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) Operating cash flow significantly increased in H1 2025, while investing cash outflow decreased and financing activities shifted to a net use of cash Cash Flow Summary (in thousands) | Activity | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2024 | | :--- | :--- | :--- | | Net cash provided by operating activities | $75,241 | $41,682 | | Net cash used in investing activities | $(7,631) | $(16,497) | | Net cash provided by (used in) financing activities | $(22,052) | $5,664 | | **Net increase in cash and cash equivalents** | **$46,880** | **$29,567** | [Notes to Condensed Consolidated Financial Statements](index=13&type=section&id=Notes%20to%20Condensed%20Consolidated%20Financial%20Statements) Notes provide detailed insights into revenue, investments, fair value measurements, equity changes, debt structure, and commitments - In Q2 2025, the company entered into a Share Purchase Agreement with Sumitomo Mitsui Trust Bank, selling **3,752,965 shares** of Class A common stock for net proceeds of **$49.8 million**[70](index=70&type=chunk) - The Board of Directors increased the stock repurchase authorization by **$50 million** in February 2025 and another **$30 million** in August 2025, bringing the total to **$220 million**. As of June 30, 2025, **$57.2 million** remained available[75](index=75&type=chunk)[77](index=77&type=chunk)[78](index=78&type=chunk) - In May 2024, the company amended its Term Loan Facility, increasing the principal amount to **$438.0 million** and extending the maturity to February 2030[111](index=111&type=chunk) - The company has unfunded investment commitments of **$126.6 million** as of June 30, 2025, up from **$90.5 million** at year-end 2024[138](index=138&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=39&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses financial performance, highlighting AUM growth, revenue and expense trends, non-GAAP measures, liquidity, and capital resources [Results of Operations](index=45&type=section&id=Results%20of%20Operations) H1 2025 saw increased operating revenues and decreased expenses, leading to significant improvements in operating and net income Revenue Breakdown (in thousands) | Revenue Type | H1 2025 | H1 2024 | Change % | | :--- | :--- | :--- | :--- | | Management fees | $211,239 | $195,728 | +8% | | Incentive fees | $31,326 | $26,155 | +20% | | **Total operating revenues** | **$245,503** | **$225,820** | **+9%** | Expense Breakdown (in thousands) | Expense Type | H1 2025 | H1 2024 | Change % | | :--- | :--- | :--- | :--- | | Employee compensation and benefits | $157,103 | $167,602 | -6% | | General, administrative and other | $53,825 | $53,343 | +1% | | **Total operating expenses** | **$210,928** | **$220,945** | **-5%** | - The **6% decrease** in H1 2025 employee compensation was primarily driven by a **$13.0 million (31%) reduction** in partnership interest-based compensation, partially offset by a **$5.2 million (55%) increase** in carried interest compensation[224](index=224&type=chunk) [Fee-Paying AUM](index=49&type=section&id=Fee-Paying%20AUM) Fee-Paying AUM (FPAUM) and total AUM significantly increased in H1 2025, driven by contributions and positive market value changes FPAUM Roll-Forward for Six Months Ended June 30, 2025 (in millions) | FPAUM Activity | Private Markets | Absolute Return | Total FPAUM | | :--- | :--- | :--- | :--- | | Balance, beginning of period | $42,717 | $22,048 | $64,765 | | Contributions | $3,707 | $977 | $4,684 | | Withdrawals | $(79) | $(517) | $(596) | | Distributions | $(1,045) | $(78) | $(1,123) | | Change in market value | $53 | $1,065 | $1,118 | | **Balance, end of period** | **$45,461** | **$23,612** | **$69,073** | - Contracted, not yet Fee-Paying AUM (CNYFPAUM) stood at **$8.7 billion** as of June 30, 2025, an increase from **$8.2 billion** at the end of 2024[239](index=239&type=chunk) - Total Assets Under Management (AUM) increased by **$5.9 billion (7%)** to **$85.9 billion** during the first six months of 2025[245](index=245&type=chunk) [Non-GAAP Financial Measures](index=52&type=section&id=Non-GAAP%20Financial%20Measures) Non-GAAP measures like Fee-Related Earnings (FRE), Adjusted EBITDA, and Adjusted Net Income (ANI) showed significant improvement in H1 2025 Key Non-GAAP Financial Measures (in thousands, except per share data) | Metric | H1 2025 | H1 2024 | | :--- | :--- | :--- | | Fee-Related Revenue | $206,120 | $192,386 | | Fee-Related Earnings | $88,274 | $77,373 | | Fee-Related Earnings Margin | 43% | 40% | | Adjusted EBITDA | $102,892 | $87,840 | | Adjusted Net Income | $67,364 | $56,598 | | Adjusted Net Income Per Share | $0.34 | $0.30 | [Liquidity and Capital Resources](index=58&type=section&id=Liquidity%20and%20Capital%20Resources) The company maintains strong liquidity with significant cash and revolver availability, managing capital through investments, debt, and shareholder returns - The company maintains a strong liquidity position with **$136.3 million** in cash and **$50.0 million** available on its revolver as of June 30, 2025[268](index=268&type=chunk) - The stock repurchase plan authorization was increased to **$220 million**. In H1 2025, **$24.9 million** was used to settle employee equity awards[284](index=284&type=chunk)[285](index=285&type=chunk) - The payable under the Tax Receivable Agreement (TRA) was **$60.6 million** as of June 30, 2025, with an increase of approximately **$9.0 million** during the period due to an exchange of partnership units[287](index=287&type=chunk) - A quarterly dividend of **$0.11 per share** of Class A common stock was declared on August 4, 2025[281](index=281&type=chunk) [Quantitative and Qualitative Disclosures about Market Risk](index=63&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20about%20Market%20Risk) The company's market risk primarily stems from fund investment performance and interest rate sensitivity on its floating-rate debt - The company's main market risk is tied to the performance of its funds' investments, which impacts management fees, incentive fees, and investment income[297](index=297&type=chunk) - A **100 basis point** increase in the SOFR would result in an estimated **$4.3 million** increase in annual interest expense on the company's floating-rate debt, before considering the effect of interest rate hedges[298](index=298&type=chunk) [Controls and Procedures](index=63&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded that disclosure controls and procedures were effective, with no material changes to internal control over financial reporting - The principal executive officer and principal financial officer concluded that the company's disclosure controls and procedures were effective as of June 30, 2025[300](index=300&type=chunk) - No material changes were made to the internal control over financial reporting during the three months ended June 30, 2025[301](index=301&type=chunk) Part II [Legal Proceedings](index=64&type=section&id=Item%201.%20Legal%20Proceedings) The company is involved in routine legal proceedings, but management does not anticipate a material impact on financial statements - Management does not expect current litigation to have a material impact on the company's financial condition or results of operations[303](index=303&type=chunk) [Risk Factors](index=64&type=section&id=Item%201A.%20Risk%20Factors) No material changes to the company's risk factors were reported since the last annual filing - No material changes to risk factors were reported for the period[305](index=305&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=64&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) The company did not make open market purchases of equity securities in Q2 2025, aside from employee equity award settlements - The company did not purchase any shares of Class A common stock or warrants during the three months ended June 30, 2025, apart from shares withheld for employee tax obligations on vested RSUs[306](index=306&type=chunk) [Other Information](index=64&type=section&id=Item%205.%20Other%20Information) No directors or executive officers adopted or terminated insider trading plans during the second quarter of 2025 - No directors or executive officers adopted or terminated an insider trading plan (Rule 10b5-1 or other) during Q2 2025[313](index=313&type=chunk)
Atlassian (TEAM) - 2025 Q4 - Annual Results
2025-08-07 20:14
Atlassian Announces Fourth Quarter and Fiscal Year 2025 Results Quarterly revenue of $1,384 million, up 22% year-over-year Quarterly subscription revenue of $1,313 million, up 23% year-over-year Quarterly GAAP operating margin of (2)% and non-GAAP operating margin of 24% Quarterly cash flow from operations of $375 million and free cash flow of $360 million Team Anywhere/San Francisco (August 7, 2025) — Atlassian Corporation (NASDAQ: TEAM), a leading provider of team collaboration and productivity software, ...
Dynavax(DVAX) - 2025 Q2 - Quarterly Report
2025-08-07 20:14
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ Form 10-Q __________________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numb ...
TrueCar(TRUE) - 2025 Q2 - Quarterly Report
2025-08-07 20:14
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-36449 | TRUECAR, INC. | | --- | | (Exact name of registrant as specified in its charter) | | Delaware 04-3807511 | | (State or other jurisdiction of (I.R.S. Employer | | incorporation or organization) Identification Number) | | 225 Santa Monica Blvd, 12th Floor | | Santa Monica, California 90401 | | (800) 200-2000 | | (Address, including zip code, and telephone number, including area code, ...
scPharmaceuticals (SCPH) - 2025 Q2 - Quarterly Report
2025-08-07 20:14
Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38293 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCPHARMACEUTICALS INC. (Exact name of registrant as specified in its charter) Delaware 46-5184075 (State or other jurisdiction of inc ...